Prolactin levels are associated with lupus activity, lupus anticoagulant, and poor outcome in pregnancy

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 218-226

  Jara, Luis J ^a,b   Pacheco Reyes, Heidi ^a   Medina, Gabriela ^a   Angeles, Ulises ^a   Cruz Cruz, Polita ^a   Saavedra, Miguel A ^a,b  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Lupus anticoagulant; Lupus pregnancy outcome; Prolactin

Indexed keywords

LUPUS ANTICOAGULANT; PROLACTIN;

ADULT; ANALYSIS OF VARIANCE; ANTIPHOSPHOLIPID SYNDROME; CHI SQUARE TEST; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; FETUS OUTCOME; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; FISHER EXACT TEST; HUMAN; LOW BIRTH WEIGHT; MOTHER FETUS RELATIONSHIP; OBSTETRICS; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURITY; PROLACTIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS; STUDENT T TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; THIRD TRIMESTER PREGNANCY;

EID: 34948815580     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.024     Document Type: Conference Paper

References (21)

1. RAMSEY-GOLDMAN, R. 1988. Pregnancy in systemic lupus erythematosus. Rhem. Dis. Clin. North Am. 14: 169-185.
2. CLOWSE, M.E., L.S. MAGDER, F. WITTER, et al. 2006. Early risk factors for pregnancy loss in lupus. Obstet. Gynecol. 107: 293-299
3. RAMSEY-GOLDMAN, R., J.E. KUTZER, L.H. KULLER, et al. 1993. Pregnancy outcome and anti-cardiolipin antibody in women with systemic lupus erythematosus. Am. J. Epidemiol. 138: 1057-1069.
4. MURPHY, V.E., R. SMITH, R.W.B. GILES, et al. 2006. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr. Rev. 27: 141-169.
5. KANIK, K.S. & R.L. WILDER. 2000. Hormonal alterations in rheumatoid arthritis, including the effects of pregnancy. Rheum. Dis. Clin. North Am. 26: 805-823.
6. WALKER, S.E. & J.D. JACOBSON. 2000. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases. Rheum. Dis. Clin. North Am. 26: 713-736.
7. JARA-QUEZADA, L., A. GRAEF & C. LAVALLE. 1991. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J. Rheumatol. 18: 349-353.
8. RUIZ-IRASTORZA, G. & M.A. KHAMASHTA. 2004. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 13: 679-682.
9. TAN, E.M., A.S. COHEN, J.F. FRIES, et al. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25: 1271-1277.
10. MCMURRAY, R.W., D. KEISLER, S. IZUI, et al. 1993. Effects of parturition, suckling and pseudopregnancy on variables of disease activity in the B/W mouse model of systemic lupus erythematosus. J. Rheumatol. 20: 1143-1151.
11. PETRI, M., D. CHANG. 1995. Longitudinal analysis of prolactin and disease activity in SLE. (Abstract) Arthritis Rheum. 38: S220.
12. HIRAHARA, F., N. ANDOH, K. SAWAI, et al. 1998. Hyperprolactinemic recurrent miscarriage and results of randomized bromocriptine treatment trials. Fertil. Steril. 70: 246-252.
13. DORIA, A., M. CUTOLO, A. GHIRARDELLO, et al. 2002. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 47: 202-209.
14. SHOENFELD, Y. & M. BLANK. 2004. Autoantibodies associated with reproductive failure. Lupus 13: 643-648.
15. BUSKILA, D., M. BEREZIN, H. GUR, et al. 1995. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 8: 415-424.
16. NEIDHART, M. 1996. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J. Rheumatol. 23: 476-481.
17. BLANK, M., I. KRAUSE, D. BUSKILA, et al. 1995. Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell Immunol. 162: 114-122.
18. LAKASING, L., J.S. CAMPA, R. POSTON, et al. 1999. Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome. Am. J. Obstet. Gynecol. 181: 180-189.
19. PIERRO, E., C.L. ANDREANI, N. LAZZARRIN, et al. 1999. Effect of anticardiolipin antibodies on prolactin and insulin-like growth factor binding protein-1 production by human decidual cells. Am. J. Reprod. Immunol. 41: 209-216.
20. MAK, I.Y.H., J.J. BROSENS, M. CHRISTIAN M, et al. 2002. Regulated expression of signal transducer and activator of transcription, stat5, and its enhancement of PRL expression in human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 87: 2581-2588.
21. FRANCIS, J., R. RAI, N.J. SEBIRE, et al. 2006. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome. Mol. Human Reprod. 12: 435-442.